SYRE compared with ORKA: revenue, margins and what each company keeps, and the suppliers and customers both name

SYRESpyre Therapeutics, Inc.

Mkt capRevenueRevenue

ORKAOruka Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SYRESpyre Therapeutics, Inc.

ORKAOruka Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SYRE 5

—WuXi Biologics (Hong Kong)unlistedsupplier

—Paragonunlistedsupplier

—WuXi Biologicsunlistedsupplier

—Equiniti Trust Company LLC (f/k/a American Stock Transfer & Trust Company LLC)unlistedsupplier

1 more · SYRE chain ›

Shared 0

No disclosed counterparties: ORKA.

Only ORKA 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

SYRESpyre Therapeutics, Inc.

96.44▼−2.55%

Mkt cap$8.5B

ORKAOruka Therapeutics, Inc.

96.24▼−0.42%· post 98.76

ClosedOct 30 '26

Mkt cap$6.4B

Compare

ClosedOct 30 '26

SYRESpyre Therapeutics, Inc.

ORKAOruka Therapeutics, Inc.

96.44▼−2.55%

Price

96.24▼−0.42%post 98.76

$8.5B

Mkt cap

$6.4B

SYRE96.44▼−2.55%vsORKA96.24▼−0.42%ClosedOct 30 '26